Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Sponsor: Baylor College of Medicine
Listed as NCT00299312, this observational or N/A phase trial focuses on MECP2 Duplication Disorder and Rett Syndrome and remains completed. Sponsored by Baylor College of Medicine, it has been updated 8 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2020 — Jan 2021 [monthly]
Completed
-
Aug 2019 — Sep 2020 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Mar 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Boston Children's Hospital
- Children's Hospital of Philadelphia
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Greenwood Genetic Center
- Rare Diseases Clinical Research Network
- Rush University Medical Center
- UCSF Benioff Children's Hospital Oakland
- University of Alabama at Birmingham
- University of California, San Diego
- University of Colorado, Denver
- University of Rochester
- University of South Florida
- Vanderbilt University
For direct contact, visit the study record on ClinicalTrials.gov .